ArticleGut microbes2026
Microbial metabolite Enterobactin impairs mitochondrial respiration and alleviates colitis.
Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND AND
aimsHost-microbe interactions critically shape cellular metabolism and immune responses. The bacterial siderophore enterobactin (Ent) is known for pilfering iron from the host, but recent evidence suggests that it may also deliver iron to host mitochondria. Its impact on mitochondrial respiration, however, remains poorly understood. Here, we assess the interplay among Ent, iron, and lipocalin-2 (Lcn2, which sequesters Ent) on mitochondrial function. We also examine the effects of the 2, 3-dihydroxybenzoic acid (2, 3-DHBA), the monomeric derivative of Ent, and the mammalian siderophore 2, 5-DHBA in a murine model of colitis.
methodsMurine bone marrow-derived macrophages (BMDMs) and the human model intestinal epithelial cells (IEC) were treated with Ent, with or without iron or rec-Lcn2, and mitochondrial respiration was assessed via Seahorse XFe96 analyzer. For
resultsIron-free Ent impaired mitochondrial oxidative phosphorylation in BMDMs and IEC, as evidenced by reduced ATP production and elevated reactive oxygen species. These effects of Ent were mitigated by iron saturation or upon co-administered with rec-Lcn2. Intriguingly, administration of 2, 3-DHBA, but not 2, 5-DHBA, to mice with DSS-induced colitis attenuated inflammation, increased expression of tight junction proteins, preserved epithelial architecture, and promoted mucosal repair. 2, 3-DHBA treatment also enhanced mitochondrial biogenesis, dynamics, and redox balance.
conclusionsEnt in its 2, 3-DHBA form confers mucosal protection, despite its inhibitory effects on mitochondrial respiration. These findings suggest that modulating mitochondrial activity, thus reducing cellular metabolism, may be beneficial during colitis and position 2, 3-DHBA as a promising microbiota-derived metabolite for therapeutic intervention in inflammatory bowel disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.